This manuscript addresses a key question in T lymphocyte biology, which is still largely unanswered: the involvement and putative function of microtubules in immunological synapse generation and function in T cell activation. The discovery that the plus-end microtubule-associated protein EB1 physically interacts with the T cell receptor intracellular regions and conditions their trafficking to the immunological synapse and their function in signal transduction appears to me as a very interesting and exciting breakthrough. Some points however need to be improved to make the data and the conclusions more convincing.
Mayor points: Figure 1  1) Fig 1 B . According to the total lysate Western Blot, the level of expression of the different CD8-ITAM constructs is very different. Only those very highly expressed proteins seemed to bind to EB1-HA. The authors should compare similar levels of expression in order to be able to draw their conclusions. They should also have some negative control over-expressed proteins to make sure that the co-immunoprecipitation is not only due to a massive overexpression in Cos cells.
2) Fig 1 C:
In the same line, a control of the level of GST-fusion proteins used for the pull down experiment should be included. 3) Fig 1D: The co-immunoprecipitaion of CD3 gamma and delta-epsilon with EB1 is not visible in the figure and should be discussed differently in the text. Either these CD3 chains are poorly biotinilated, (which does not seem to be the case in the CD3zeta immunoprecipitate lane), or EB1 IP enriches TCRzeta (in partial agreement with Fig 1A) and TCRalpha-beta (which seems puzzling at this point, but might be interesting). Signal in left panels is too thick and not enough spatially resolved in left panels, and it is too tiny to be visible on the right panels. I was not even able to get a clear message when enlarging the images on the computer. I should say that the merge of three colors makes the visualization even harder. In the present display this figure is not legible and needs to be improved. I think the message in Fig 2 might be there, but the authors need to find the way to make it better legible to the present and future (when published) readers. Otherwise it is not convincing. I think this type of data is much more understandable in Fig 3 and figure) . Are the authors sure that the effect of EB1 silencing on TCRzeta is specific of EB1 and not an off target effect? In Materials and Methods the authors seem to use shRNA plasmid transfection for EB1 silencing and siRNA (oligo ?) transfection and they analyze them at two different days post-transfection. This is not, in my opinion, a right control. The same type, either siRNA oligos or shRNA plasmids (ie scramble or unrelated sequences) should be used as controls and cells should be analyzed the same day post-transfection and under the same conditions. Fig 5B: The findings showing TCRzeta and LAT vesicle encountering each other in an EB-1-dependent manner appears to me as a very exciting result. This finding will be more solid if overlapping TCRzeta and LAT vesicles were properly quantified in a significant number of cells and in several experiments. The localization of TCRzeta at growing microtubules is consistent with its interaction with EB1 shown in Fig 1. It would be interesting to test whether LAT also interacts with EB1, which would facilitate zeta-LAT encounters at growing microtubules. 2) Sup Fig S6: The authors comment in the text that EB1-silenced cells accumulate less LAT at the IS. It is also striking in this figure that the accumulation of LAT in non stimulated EB1-silenced cells (EB1 KD-SEE) seems significantly higher that in the control cells (control-SEE), although the authors do not show the p values between these two conditions. This should be commented and pvalue analyzed. 3) Fig 5 C-F: In the text concerning the data in this figure, the authors describe that the levels of phosphorylation of LAT on Tyr 191 and 132 were impaired in EB1-silenced cells. In contrast, CD3zeta and ZAP phosphorylation were unaltered. I do see a significant increase in ZAPY493, in HA and SEB stimulation. These data should be more thoroughly discussed. Quantification of the pY band intensities corrected for the amount of loaded protein should be shown and data discussed accordingly. This is a very interesting paper linking the microtubule + end directed protein EB1 to the T cell receptor and vesicle transport in the immunological synapse (IS). The authors are correct that while MTOC position has been a topic of interest in the IS since the early 1980's, the role of dynamics of the + end of MTs in the IS has not been explored. They find by yeast two hybrid and coimmunoprecipitation that EB1 interacts with a subset of TCR ITAMs and then go on to show that EB1 is associated with TCR and LAT vesicles. The study suggests a new way for vesicles to be transported in a manner that is distinct from the centripetal actin flow or actin tails. Such noncentripetal movement has been observed previously, but could not be explained. Interestingly, EB1 seems to restrain this movement and suggests that other mechanisms exist in the absence of EB1 to move vesicles. The story is driven by results with the cell line Jurkat. There is some mixture of data from primary lymphocyte and lymphoblasts, but generally these are not very convincing. So I think that despite these preliminary attempts at generalizing this, the title should reflect the reliance on the cell line for the results highlighted in the title. Title should have "...in a human T cell line" added to reflect this dependence of the story on this workhorse cell line.
Major points: 1. The solid phase stimulation system utilized by the authors is essentially identical to the system implemented by Samelson and colleagues to study actin dynamics and this should be cited: Bunnell SC, Kapoor V, Trible RP, Zhang W, Samelson LE. 2001. Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT. Immunity 14: 315-29. This paper also looks at effects of colchicine and concludes that microtubules are not important for initial spreading, but are important for maintaining the contact area after 7 minutes. Therefore, this is a highly relevant paper. 2. Although the importance of the LAT tyrosines in spreading and T cell responses was established earlier, the first evidence for LAT phosphorylation associated with TCR microclusters was reported in 2005 and this paper should be cited also: Campi G, Varma R, Dustin ML. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med 202: 1031-6. 3. Figure 1B -the CD8-zetaA and -zetaB constructs didn't express well so the negative results are weak. Can they identify a shared motif between CD3epsilon and zetaC such that there is a stronger case for that specificity? 4. Figure 1E -this does not appear to be a well-controlled experiments. In addition, shouldn't zeta shift in molecular weight on stimulation? 5. In general, the data correlating EB1 and TCR vesicles is weak. There are a lot more EB1 signals that are all moving away from the center and in the vicinity, but not apparently with TCR vesicles. One might have predicted that vesicles would move outward with EB1 associated with MT was pushing them, but this does not appear to be the case. Based on the part of EB1 that binding TCR, can it being to TCR and MT at the same time? 6. The biochemical analysis in Fig 5F is not convincing that there are signaling defects in normal T cells in the absence of EB1. Quantitative results from at least 3 experiments would need to be assembled and tested for significance as the result is not visually striking as presented. 7. The data on PLCgamma in synapse is convincing, but the biochemistry is just not compelling without quantification to capture the 4 experiments one which the conclusion is based. Point by point reply to the referee's comments:
Referee #1 (Remarks to the Author): This manuscript addresses a key question in T lymphocyte biology, which is still largely unanswered: the involvement and putative function of microtubules in immunological synapse generation and function in T cell activation. The discovery that the plus-end microtubule-associated protein EB1 physically interacts with the T cell receptor intracellular regions and conditions their trafficking to the immunological synapse and their function in signal transduction appears to me as a very interesting and exciting breakthrough.
Some points however need to be improved to make the data and the conclusions more convincing.
We thank the referee by his/her positive appraisal of our work and by his/her specific comments to improve the work presented in the manuscript.
Major points: Although the ratios of co-IP CD3 / loaded CD3 allowed us to sustain that EB1 binds CD3e and CD3z but not CD3g or CD3d, we agree with the referee that the difference was not clear at first sight due to unequal transfection efficiency. Therefore, we have carried out additional experimentation to achieve more similar levels of expression. In addition, we have added the CD8-g chimaera as one of the best possible negative controls. Other negative controls include a mock control and expression of EB1-HA alone. Loading controls have also been added. We have detected the interaction of EB1-HA with the 3 ITAMs of CD3z, as well as with CD3e but not with CD3g. This is now included in panel B of Fig. 1 . We have also modified the text accordingly (Results, page 5, lines 15-18, and Discussion, page 14, lines 10-15).
2) Fig 1 C: In the same line, a control of the level of GST-fusion proteins used for the pull down experiment should be included.
We have performed new pull-down experiments, using lysates from T lymphoblasts to analyze the interaction with the human endogenous protein in T cells and the corresponding loading control for GST-fusion proteins has been added to the Figure (new panel C to Fig. 1) . We have also modified Figure 1C to show more clearly the sequences of EB1 affected in each deletion mutant.
3) Fig 1D: Fig 1A) and TCRalpha-beta (which seems puzzling at this point, but might be interesting).
We agree with the referee that the co-IP of EB1 with only part of the subunits of the TCR complex is somehow puzzling. The anti-CD3 ζ IP excludes that CD3γ, CD3δ and CD3ε are not biotin-labeled. The only explanation we can provide is that EB1 associates to a partial complex of the TCR that contains TCRαβ and CD3ζ but not the other CD3 subunits. As far as we know there are two published works that point out to a possible dissociation of cell surface expressed TCR subunits. The first is the multi-chain immune receptor oligo-oligomerization model that proposes the dissociation of TCR and CD3 subunits upon stimulation resulting in the release of an inhibitory effect of TCRαβ on the CD3 subunits (Sigalov AB (2006) . Trends in Pharmacological Sciences 27: 518-524; and references thereof). The second emerges from the observation that surface-expressed TCRαβ and CD3 (γ,δ,ε) subunits do not have the same rate of degradation in non-stimulated T cells: TCRαβ degrades faster than CD3s (San Jose and Alarcon (1999). J. Biol. Chem. 274: 33740-33746). According to this last finding, endocytosed but not degraded CD3 subunits have to assemble with newly synthesized TCRαβ in order to maintain a constant TCRαβ-CD3 stoichiometry at the plasma membrane. Because we see association of EB1 with TCRαβ and CD3ζ in non-stimulated T cells (Fig. 1D of the present paper) we rather think that EB1 interaction with TCRαβ and CD3ζ could be involved in the trafficking of the most rapidly-degraded TCR subunits to the plasma membrane. We now address this possibility in the Results section (page 6, lines 12-19). 
I think the message in Fig 2 might be there, but the authors need to find the way to make it better legible to the present and future (when published) readers. Otherwise it is not convincing. I think this type of data is much more understandable in Fig 3 and movies 1 & 2.
As suggested by the reviewer, and for the sake of clarity, we have made changes in the Figure 2 to clearly show that EB1 localizes in tips at the immune synapse and we hope it will be more informative now. Also, we think it is important for the readership to show the localization of the endogenous protein in conjugates formed by TCR stimulation with both specific peptides and bacterial super-antigens. We have moved the maximal projections of OT-II conjugates to the supplemental material (Suppl. Figure S2A ) and a single plane has been placed instead.
Figure 4 1) Fig 4D lower panels are supposed to show EB1 KD cells, yet the EB1 labeling is rather extensive (comparable to APC labeling on the Max proj figure). Are the authors sure that the effect of EB1 silencing on TCRzeta is specific of EB1 and not an off target effect?
In We do not agree with the referee that the labeling for EB1 appears to be somehow similar in the KD cells. The amount of EB1 in the tips of the microtubules as well as at the centrosome is rather lower than in control cells, even in the maximal projection. We have now included quantification of EB1 in the Immune synapse, which is depicted as a graph in the figure. We have changed the images showed to make this point clearer to the reader.
With respect to the material and methods section, we have made the appropriate changes to make clear that adequate controls were used in each case and that siRNA was not used as control of shRNA (or viceversa), but as a complementary tool. We thank the reviewer for raising this point, which was not correctly explained in the previous version of the manuscript.
Figure 5 1) Fig 5B: The findings showing TCRzeta and LAT vesicle encountering each other in an EB-1-dependent manner appears to me as a very exciting result. This finding will be more solid if overlapping TCRzeta and LAT vesicles were properly quantified in a significant number of cells and in several experiments. The localization of TCRzeta at growing microtubules is consistent with its interaction with EB1 shown in Fig 1. It would be interesting to test whether LAT also interacts with EB1, which would facilitate zeta-LAT encounters at growing microtubules.
We agree that the effect in the vesicle encounter is important and we have therefore quantified a significant number of vesicles in control and EB1-silenced cells with the Imaris software to analyze whether the vesicles encounter each other in the cells and if this effect is significant. Using a two-tailed ANOVA analysis, we have found the differences to be significant for the different thresholds used to analyze vesicle encounter. A 3D projection of the XY planes versus time has been included to visualize the trajectories of the vesicles during T cell stimulation. The results are now included in the new figure 5, as well as the quantification (new panel B in Fig. 5 ).
The interaction with LAT has been analyzed by co-IP, using specific conditions to preserve microtubules, such as a specific buffer, used to preserve microtubules (PHEM, Pipes 30 mM, Hepes 20 mM, Magnesium chloride and EDTA 2mM), lysis at room temperature and immunoprecipitation, as well as non-reducing conditions and Brij 96v (0.33%) detergent to preserve the TCR/CD3 complex. We have found that CD3z and LAT can co-immunoprecipitate and that this is diminished by EB1 knock-down. These results are included in the new Figure 5 (new panel C) and are quoted under Results section (Page 11, lines 22-25).
2) Sup Fig S6: The authors comment in the text that EB1-silenced cells accumulate less LAT at the IS. It is also striking in this figure that the accumulation of LAT in non stimulated EB1-silenced cells (EB1 KD-SEE) seems significantly higher that in the control cells (control-SEE), although the authors do not show the p values between these two conditions. This should be commented and pvalue analyzed.
We thank the referee for this comment. The p value has now been added to the graph, and found to be significant (Suppl Figure S7) . We have found a loss on T cell polarity by EB1 knockdown, and part of this effect is due to the delocalization of LAT far away from the trailing edge/Uropod in polarized human T lymphoblast, where it is localized in control cells. This effect provokes an increase in the localization of LAT at the cell-cell contact with the antigen presenting cell in the absence of stimulation with respect to control cells. A comment on this effect has been added to the text (Results, page 11, lines 15-19). Answer to 3) and 4):
3) Fig 5 C-F: In the text concerning the data in this figure, the authors describe that the levels of phosphorylation of LAT on Tyr 191 and 132 were impaired in EB1-silenced cells. In contrast,
We have carefully analyzed the phosphorylation of the specific bands and we have referred it to the total protein loaded. Quantification of the different experiments is provided in the graphs of the new figure 6. These results point to a slight increase in CD3z and ZAP70 phosphorylation, although not significant when all data where analyzed together. It is possible that part of the phosphorylation of these molecules may not be reversed or switched-off correctly if the activation cannot spread correctly towards LAT scaffold protein. However, we cannot assure that this is the case when EB1 is silenced. On the other hand, both LAT and PLCg1 are clearly affected by EB1 knock-down. The quantification of the western blots corresponds to the effect observed in cell conjugates for PLCg1.
Minor points 1) Fig 1 C. The labels for the different constructs are almost invisible. They should be better labeled (i.e. bigger and all on the left side) to make the figure easier to read.
The labels have been corrected in accordance with the referee's suggestion. Sup Fig S1 to make Fig 1 lighter. Figures 1E and 1F are now part of the Supplemental Fig S1. 
2) Fig 1 E and F seem not to be necessary and could be put in

3) Fig 2 : What do yellow versus white arrows mean ?
The yellow arrows mark the centrosome in Figure 2B , while white arrowheads mark tips of microtubules that correspond with CD3z vesicles/label.
4) Fig 2C: The authors should explain the sense of this experiment. For a non specialist, the MTOC, present in the centrosome is associated with minus-end microtubules. Why, a protein associated with plus-end, like EB1 should then be (or expected to be) enriched in the centrosome?
The presence of EB1 in the centrosome allows the formation of a radial array of microtubules from the centrosome (Askham, J. M., MCB 2002), which may help the formation of a microtubule network through the specific tracking of EB1 at the plus tips of microtubules. We have quoted this information throughout the manuscript, following the suggestion of the referee. Fig S6. The authors write B) The graph to the right plots the distribution of intensity/area of CD3zeta, whereas in the figure LAT is labeled. This needs to be corrected.
5) Legend to
The figure legend has been corrected. We thank the referee for his/her positive appraisal of the work presented in our manuscript. We have, however, some arguments against the suggestion that these results are only valid in the Jurkat T cell line, since the localization experiments with endogenous proteins (EB1, CD3, LAT, PLCg1) have been performed in human primary T lymphoblasts from healthy donors (see Figures 2, 4, 7 and Suppl. Figure S5 and S7) , as well as some of the signaling experiments (Figures 6 and 7) and immunoprecipitations (Suppl. Figure S1 ). It is true that TCR signaling has been extensively analyzed in the Jurkat cell line, which is a widely accepted model for TCR signaling. We have included the reference in the results section and in the discussion, following the indications of the referee (pages 9 and 13, respectively). We have included the reference on the role of LAT tyrosines in spreading and T cells responses (Discussion, page 16). Figure 1B -the CD8-zetaA and -zetaB constructs didn't express well so the negative results are weak. Can they identify a shared motif between CD3epsilon and zetaC such that there is a stronger case for that specificity?
Referee #2 (Remarks to the Author): This is a very interesting paper linking the microtubule + end directed protein EB1 to the T cell receptor and vesicle transport in the immunological synapse (IS
Although the importance of the LAT tyrosines in spreading and T cell responses was established
3.
We agree that there are differences in the levels of expression of the different constructs. We have made additional experimentation to obtain similar levels for the different constructs.
Indeed, we have added CD8-γ chimaera as a negative control for interaction. This is now added as the new panel B of Figure 1 .
Figure 1E-this does not appear to be a well-controlled experiments. In addition, shouldn't zeta shift in molecular weight on stimulation?
We agree that in Figure 1E there is no control antibody to assay that it is a specific stimulation and IP. As suggested by the reviewer 1, we have moved the Figure 1E and F to the Suppl. Figure S1 to make the Figure 1 less complex. With respect to the shift in mobility, it seems clear that only a small portion of CD3z becomes fully phosphorylated after extensive TCR crosslinking. This amount of phosphorylated CD3z is difficult to be detected with a total antibody. Nevertheless, in Figure 1F we can observe an activation-induced reduction in the mobility of part of CD3z that corresponds to phosphorylated CD3z. The portion of EB1 visualized as moving tips corresponds to the fraction of EB1 bound to the microtubules, which is the EB1 population that correlates with CD3z. Since EB1 is found as an homodimer when bound to the microtubules, and CD3z is found as an homodimer when interacting with EB1 (Fig. 1) , we propose that EB1 may interact at the same time with microtubules and CD3z, and that the vesicles can be bound to different EB1 molecules in different tips of microtubules, going in and out of the IS.
Indeed, we have analyzed the movement of CD3 vesicles with the Imaris software and found that they correspond to this kind of movement, and it fits well with an algorithm that considers their movement as interconnected elements ( Figure 5 ). We propose that the linker for CD3 and LAT containing-vesicles is EB1 bound at the plus tips of microtubules (see Discussion). Fig 5F is 
The biochemical analysis in
The data on PLCgamma in synapse is convincing, but the biochemistry is just not compelling without quantification to capture the 4 experiments one which the conclusion is based.
Answer to comments 6 and 7:
Following the indications of the referee, we have made densitometric analyses of the bands corresponding to the phosphorylated proteins and the corresponding loading controls and we have added them in the figures (new Figure 6 and Figure 7) . To avoid an excess of information we have moved the data from the western blot to a new figure (see new figure 6 ) and omitted the data from super-antigen B, since we consider that these are already represented by super-antigen E. The results point to a slight increase in CD3z and ZAP70 phosphorylation, although not significant when all data where analyzed together. It is possible that part of the phosphorylation of these molecules may not be reversed or switched-off correctly if the activation cannot spread correctly towards LAT scaffold protein. However, we can not assure that this is the case when EB1 is silenced. On the other hand, both LAT and PLCg1 phosphorylation is clearly affected by EB1 knock-down. The quantification of the western blots corresponds to the observed effect in tyrosine 783 from PLCg1 in the SEE-specific T lymphoblasts conjugated with APCs.
